Sign in
4

Changes in Ownership

Arcus Biosciences, Inc. Filed Acc 0001771961-26-000006

Chief Accounting Officer sold 2,827 shares at $30.00 ($84,810)

  • Chief Accounting Officer acquired 2,827 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Azoy Alexander · Chief Accounting Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-08-21 Exercise or conversion : show line 1 in the form 10b5-1 +2,827 $15.44 $43,649 42,408 D
2026-08-21 Sale : show line 2 in the form 10b5-1 −2,827 $30.00 $84,810 39,581 D
Open-market sales · 2,827 sh · avg $30.00 · $84,810

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-08-21 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) −2,827 3,073 D
Loading xslF345X06/wk-form4_1787608336.xml…